Article citationsMore>>

Ambrose, E.E., Latham, T.S., Songoro, P., Charles, M., Lane, A.C., Stuber, S.E., et al. (2023) Hydroxyurea with Dose Escalation for Primary Stroke Risk Reduction in Children with Sickle Cell Anaemia in Tanzania (SPHERE): An Open-Label, Phase 2 Trial. The Lancet Haematology, 10, e261-e271.
https://doi.org/10.1016/s2352-3026(22)00405-7

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top